Report from the American Society of Transplantation on frailty in solid organ transplantation

Jon Kobashigawa, Darshana Dadhania, Sangeeta Bhorade, Deborah Adey, Joseph R Berger, Geetha Bhat, Marie Budev, Andres Duarte-Rojo, Michael Dunn, Shelley Hall, Meera N. Harhay, Kirsten L. Johansen, Susan Joseph, Cassie C. Kennedy, Evan Kransdorf, Krista L. Lentine, Raymond J. Lynch, Mara McAdams-DeMarco, Shunji Nagai, Michael Olymbios & 14 others Jignesh Patel, Sean Pinney, Joanna Schaenman, Dorry L. Segev, Palak Shah, Lianne G. Singer, Jonathan P. Singer, Christopher Sonnenday, Puneeta Tandon, Elliot Tapper, Stefan G. Tullius, Michael Wilson, Martin Zamora, Jennifer C. Lai

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by the American Society of Nephrology (ASN), the American Society of Transplant Surgeons (ASTS), and the Canadian Society of Transplantation (CST) took place on February 11, 2018 in Phoenix, Arizona. Input from the transplant community through scheduled conference calls enabled wide discussion of current concepts in frailty, exploration of best practices for frailty risk assessment of transplant candidates and for management after transplant, and development of ideas for future research. A current understanding of frailty was compiled by each of the solid organ groups and is presented in this paper. Frailty is a common entity in patients with end-stage organ disease who are awaiting organ transplantation, and affects mortality on the waitlist and in the posttransplant period. The optimal methods by which frailty should be measured in each organ group are yet to be determined, but studies are underway. Interventions to reverse frailty vary among organ groups and appear promising. This conference achieved its intent to highlight the importance of frailty in organ transplantation and to plant the seeds for further discussion and research in this field.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Organ Transplantation
Transplants
Heart-Lung Transplantation
Practice Guidelines
Liver Transplantation
Kidney Transplantation
Seeds
Mortality
Research

Keywords

  • clinical research/practice
  • heart disease
  • immune regulation
  • kidney disease
  • kidney transplantation/nephrology
  • liver disease
  • liver transplantation/hepatology
  • lung disease
  • lung transplantation/pulmonology

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Report from the American Society of Transplantation on frailty in solid organ transplantation. / Kobashigawa, Jon; Dadhania, Darshana; Bhorade, Sangeeta; Adey, Deborah; Berger, Joseph R; Bhat, Geetha; Budev, Marie; Duarte-Rojo, Andres; Dunn, Michael; Hall, Shelley; Harhay, Meera N.; Johansen, Kirsten L.; Joseph, Susan; Kennedy, Cassie C.; Kransdorf, Evan; Lentine, Krista L.; Lynch, Raymond J.; McAdams-DeMarco, Mara; Nagai, Shunji; Olymbios, Michael; Patel, Jignesh; Pinney, Sean; Schaenman, Joanna; Segev, Dorry L.; Shah, Palak; Singer, Lianne G.; Singer, Jonathan P.; Sonnenday, Christopher; Tandon, Puneeta; Tapper, Elliot; Tullius, Stefan G.; Wilson, Michael; Zamora, Martin; Lai, Jennifer C.

In: American Journal of Transplantation, 01.01.2018.

Research output: Contribution to journalArticle

Kobashigawa, J, Dadhania, D, Bhorade, S, Adey, D, Berger, JR, Bhat, G, Budev, M, Duarte-Rojo, A, Dunn, M, Hall, S, Harhay, MN, Johansen, KL, Joseph, S, Kennedy, CC, Kransdorf, E, Lentine, KL, Lynch, RJ, McAdams-DeMarco, M, Nagai, S, Olymbios, M, Patel, J, Pinney, S, Schaenman, J, Segev, DL, Shah, P, Singer, LG, Singer, JP, Sonnenday, C, Tandon, P, Tapper, E, Tullius, SG, Wilson, M, Zamora, M & Lai, JC 2018, 'Report from the American Society of Transplantation on frailty in solid organ transplantation', American Journal of Transplantation. https://doi.org/10.1111/ajt.15198
Kobashigawa, Jon ; Dadhania, Darshana ; Bhorade, Sangeeta ; Adey, Deborah ; Berger, Joseph R ; Bhat, Geetha ; Budev, Marie ; Duarte-Rojo, Andres ; Dunn, Michael ; Hall, Shelley ; Harhay, Meera N. ; Johansen, Kirsten L. ; Joseph, Susan ; Kennedy, Cassie C. ; Kransdorf, Evan ; Lentine, Krista L. ; Lynch, Raymond J. ; McAdams-DeMarco, Mara ; Nagai, Shunji ; Olymbios, Michael ; Patel, Jignesh ; Pinney, Sean ; Schaenman, Joanna ; Segev, Dorry L. ; Shah, Palak ; Singer, Lianne G. ; Singer, Jonathan P. ; Sonnenday, Christopher ; Tandon, Puneeta ; Tapper, Elliot ; Tullius, Stefan G. ; Wilson, Michael ; Zamora, Martin ; Lai, Jennifer C. / Report from the American Society of Transplantation on frailty in solid organ transplantation. In: American Journal of Transplantation. 2018.
@article{9e09cf70bf844e52bcb3433c6b9f3d94,
title = "Report from the American Society of Transplantation on frailty in solid organ transplantation",
abstract = "A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by the American Society of Nephrology (ASN), the American Society of Transplant Surgeons (ASTS), and the Canadian Society of Transplantation (CST) took place on February 11, 2018 in Phoenix, Arizona. Input from the transplant community through scheduled conference calls enabled wide discussion of current concepts in frailty, exploration of best practices for frailty risk assessment of transplant candidates and for management after transplant, and development of ideas for future research. A current understanding of frailty was compiled by each of the solid organ groups and is presented in this paper. Frailty is a common entity in patients with end-stage organ disease who are awaiting organ transplantation, and affects mortality on the waitlist and in the posttransplant period. The optimal methods by which frailty should be measured in each organ group are yet to be determined, but studies are underway. Interventions to reverse frailty vary among organ groups and appear promising. This conference achieved its intent to highlight the importance of frailty in organ transplantation and to plant the seeds for further discussion and research in this field.",
keywords = "clinical research/practice, heart disease, immune regulation, kidney disease, kidney transplantation/nephrology, liver disease, liver transplantation/hepatology, lung disease, lung transplantation/pulmonology",
author = "Jon Kobashigawa and Darshana Dadhania and Sangeeta Bhorade and Deborah Adey and Berger, {Joseph R} and Geetha Bhat and Marie Budev and Andres Duarte-Rojo and Michael Dunn and Shelley Hall and Harhay, {Meera N.} and Johansen, {Kirsten L.} and Susan Joseph and Kennedy, {Cassie C.} and Evan Kransdorf and Lentine, {Krista L.} and Lynch, {Raymond J.} and Mara McAdams-DeMarco and Shunji Nagai and Michael Olymbios and Jignesh Patel and Sean Pinney and Joanna Schaenman and Segev, {Dorry L.} and Palak Shah and Singer, {Lianne G.} and Singer, {Jonathan P.} and Christopher Sonnenday and Puneeta Tandon and Elliot Tapper and Tullius, {Stefan G.} and Michael Wilson and Martin Zamora and Lai, {Jennifer C.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/ajt.15198",
language = "English (US)",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Report from the American Society of Transplantation on frailty in solid organ transplantation

AU - Kobashigawa, Jon

AU - Dadhania, Darshana

AU - Bhorade, Sangeeta

AU - Adey, Deborah

AU - Berger, Joseph R

AU - Bhat, Geetha

AU - Budev, Marie

AU - Duarte-Rojo, Andres

AU - Dunn, Michael

AU - Hall, Shelley

AU - Harhay, Meera N.

AU - Johansen, Kirsten L.

AU - Joseph, Susan

AU - Kennedy, Cassie C.

AU - Kransdorf, Evan

AU - Lentine, Krista L.

AU - Lynch, Raymond J.

AU - McAdams-DeMarco, Mara

AU - Nagai, Shunji

AU - Olymbios, Michael

AU - Patel, Jignesh

AU - Pinney, Sean

AU - Schaenman, Joanna

AU - Segev, Dorry L.

AU - Shah, Palak

AU - Singer, Lianne G.

AU - Singer, Jonathan P.

AU - Sonnenday, Christopher

AU - Tandon, Puneeta

AU - Tapper, Elliot

AU - Tullius, Stefan G.

AU - Wilson, Michael

AU - Zamora, Martin

AU - Lai, Jennifer C.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by the American Society of Nephrology (ASN), the American Society of Transplant Surgeons (ASTS), and the Canadian Society of Transplantation (CST) took place on February 11, 2018 in Phoenix, Arizona. Input from the transplant community through scheduled conference calls enabled wide discussion of current concepts in frailty, exploration of best practices for frailty risk assessment of transplant candidates and for management after transplant, and development of ideas for future research. A current understanding of frailty was compiled by each of the solid organ groups and is presented in this paper. Frailty is a common entity in patients with end-stage organ disease who are awaiting organ transplantation, and affects mortality on the waitlist and in the posttransplant period. The optimal methods by which frailty should be measured in each organ group are yet to be determined, but studies are underway. Interventions to reverse frailty vary among organ groups and appear promising. This conference achieved its intent to highlight the importance of frailty in organ transplantation and to plant the seeds for further discussion and research in this field.

AB - A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by the American Society of Nephrology (ASN), the American Society of Transplant Surgeons (ASTS), and the Canadian Society of Transplantation (CST) took place on February 11, 2018 in Phoenix, Arizona. Input from the transplant community through scheduled conference calls enabled wide discussion of current concepts in frailty, exploration of best practices for frailty risk assessment of transplant candidates and for management after transplant, and development of ideas for future research. A current understanding of frailty was compiled by each of the solid organ groups and is presented in this paper. Frailty is a common entity in patients with end-stage organ disease who are awaiting organ transplantation, and affects mortality on the waitlist and in the posttransplant period. The optimal methods by which frailty should be measured in each organ group are yet to be determined, but studies are underway. Interventions to reverse frailty vary among organ groups and appear promising. This conference achieved its intent to highlight the importance of frailty in organ transplantation and to plant the seeds for further discussion and research in this field.

KW - clinical research/practice

KW - heart disease

KW - immune regulation

KW - kidney disease

KW - kidney transplantation/nephrology

KW - liver disease

KW - liver transplantation/hepatology

KW - lung disease

KW - lung transplantation/pulmonology

UR - http://www.scopus.com/inward/record.url?scp=85059023059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059023059&partnerID=8YFLogxK

U2 - 10.1111/ajt.15198

DO - 10.1111/ajt.15198

M3 - Article

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -